Protalix BioTherapeutics
PLX
#8601
Rank
NZ$0.44 B
Marketcap
NZ$5.30
Share price
-5.23%
Change (1 day)
70.10%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): NZ$0.54

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.57. In 2025 the company made an earnings per share (EPS) of NZ-$0.15 a decrease over its 2024 EPS that were of NZ$0.07312.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.54-468.87%
2025NZ-$0.15-300%
2024NZ$0.07312-66.67%
2023NZ$0.22-138.71%
2022NZ-$0.57-50%
2021NZ-$1.13181.82%
2020NZ-$0.40-82.11%
2019NZ-$2.25-31.67%
2018NZ-$3.29-72.31%
2017NZ-$11.88124.14%
2016NZ-$5.30-147.54%
2015NZ$11.15-290.63%
2014NZ-$5.856.67%
2013NZ-$5.48130.77%
2012NZ-$2.38-69.77%
2011NZ-$7.8619.44%
2010NZ-$6.58-12.2%
2009NZ-$7.4936.67%
2008NZ-$5.48-37.5%
2007NZ-$8.7750%
2006NZ-$5.853.23%
2005NZ-$5.67138.46%
2004NZ-$2.38-74%
2003NZ-$9.14-0%
2002NZ-$9.14-50%
2001NZ-$18.28233.33%
2000NZ-$5.48-84.21%
1999NZ-$34.73-24%
1998NZ-$45.70-600%
1997NZ$9.14-16.67%
1996NZ$10.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.30 129.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.74 2,148.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.20-135.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$0.82 45.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel